Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Cash Flow-to-Debt Ratio
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥44.34 Million could theoretically repay 0% of its total liabilities (CN¥2.06 Billion) in one year. See how much free cash does Hainan Huluwa Pharmaceutical Group Co Lt generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hainan Huluwa Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Hainan Huluwa Pharmaceutical Group Co Ltd across 10 annual periods. Also explore 605199 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)
Year-by-year debt coverage analysis for Hainan Huluwa Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see 605199 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | CN¥136.85 Million | CN¥2.14 Billion | ▲ +195.0% |
| 2024 | -0.07x | CN¥-149.12 Million | CN¥2.22 Billion | ▼ -551.7% |
| 2023 | 0.01x | CN¥28.25 Million | CN¥1.90 Billion | ▼ -91.9% |
| 2022 | 0.18x | CN¥238.71 Million | CN¥1.30 Billion | ▲ +49.2% |
| 2021 | 0.12x | CN¥102.48 Million | CN¥830.41 Million | ▲ +2161.5% |
| 2020 | 0.01x | CN¥3.30 Million | CN¥604.68 Million | ▼ -98.3% |
| 2019 | 0.33x | CN¥144.51 Million | CN¥442.67 Million | ▲ +400.4% |
| 2018 | 0.07x | CN¥31.80 Million | CN¥487.37 Million | ▼ -66.9% |
| 2017 | 0.20x | CN¥89.96 Million | CN¥455.83 Million | ▲ +23.7% |
| 2016 | 0.16x | CN¥64.96 Million | CN¥407.26 Million | — |